Cherwell Laboratories, specialists in cleanroom microbiology solutions, announces that it has recently delivered its biggest ever single order for microbial air sampling equipment to support the large-scale manufacturing programme for COVID-19 vaccine supply. The new SAS air sampling equipment will be used for the environmental monitoring of the newly built UK-based Grade A manufacturing facilities of a key specialty vaccine company.
Developed by Curiosity Diagnostics, a wholly-owned subsidiary of Scope Fluidics S.A., the PCR|ONE SARS-CoV-2 panel is now CE-marked and can be introduced to the European market. The PCR|ONE SARS-CoV-2 panel is one of the fastest tests in the world, and is uniquely suited for near patient testing. The SARS-CoV-2 product expand the menu of test available on the PCR|ONE system, which already includes methicillin-resistant Staphylococcus aureus (MRSA/MSSA panel)....
As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launched a variety of lentiviral SARS-CoV-2 pseudovirus from a wide range of coronavirus species. Different vectors can be used to express different reporters such as EGFP or luciferase, allowing the monitoring of viral entry into host cells by a variety of means....
Illumina, Inc. has donated $1 million in sequencing capabilities to the Molecular Diagnostic Reference Laboratory at Kasturba Hospital, in the Municipal Corporate of Greater Mumbai, to help expand SARS-CoV-2 sequencing capabilities in the region and support the broader genomic surveillance effort across India. Kasturba Hospital was the first hospital in Mumbai to begin sequencing SARS-CoV-2 this year and will examine how variants of the virus are being spread across India....
Nanopharm Ltd., an Aptar Pharma company and leader in contract research and development of orally inhaled and nasally delivered drug products (OINDP) and Leyden Labs, a company targeting commonalities of viral families to protect humanity from known and future viruses, have announced that they have entered into an agreement to develop nasal sprays that may provide broad protection against respiratory viruses...
PharmEnable, an AI drug discovery company unlocking challenging biological targets, announces that it has entered into a drug discovery collaboration with LifeArc, an independent UK medical research charity, to apply their respective technologies and expertise to discover novel oral antiviral drugs with activity against coronaviruses....
At the start of the COVID-19 pandemic in March 2020, Dr Mason and his team set about turning their knowledge of functional genomics to sequencing and understanding the clinical impact of the SARS-CoV-2 virus. The lab developed multiple methods to detect infections, track strain evolution, and identify biomarkers of disease course to assist with clinical identification and treatment....
MolGen B.V., a single-source supplier of DNA/RNA extraction technology and services for the life sciences and biotechnology, announce its entrance into the U.S. market with the launch of MolGen USA, a joint venture with California-based, laboratory automation experts Todaro Robotics. MolGen USA will operate a complete commercial team and product showroom at the San Diego facility....
Severe COVID-19 and Rheumatoid Arthritis (RA) share some common pathogenic mechanisms, according to a new study. The observations from the study – published in JCI Insight and led by the University of Glasgow’s Research into Inflammatory Arthritis Centre (RACE) in collaboration with the Fondazione A.Gemelli IRCCS in Italy –could help development of new treatment strategies for severe COVID-19...
SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The partnership links specimen handling, nucleic acid extraction, assay set-up, amplification, and results reporting in a seamless integration of the companies technologies...
Owlstone Medical (or the “Company”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, has announced the publication of a peer-reviewed study in Nature Scientific Reports. The paper investigates the performance of filters embedded in face masks for supporting the detection of SARS-CoV-2 as an alternative to nasopharyngeal swabs (NPS)...
Designed and manufactured in the UK, Σ–MM™ solution rapidly kills all microorganisms, including bacteria, mycobacteria and viruses, rendering specimens safe for transport, whilst preserving and stabilizing RNA/DNA for accurate molecular analysis across diagnostic platforms. The Σ–MM™ device is a highly effective single step collection....
The race is on in the diagnostics industry to develop a device that instantly detects coronavirus for use in large public spaces and airports, according to one of the UK’s top medical technology recruiters. Ivor Campbell, chief executive of Snedden Campbell, said the biggest companies are chasing the ‘holy grail’ of a rapid-test, biosensing device – similar to that used to test blood sugar levels in diabetic patients – that will identify whether a patient has Covid within a matter of seconds...
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced the launch of the Reliance SARS-CoV-2/FluA/FluB™ RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements. The Reliance SARS-CoV-2/FluA/FluB™ RT-PCR Kit (IVD) is a single molecular test designed for clinical diagnostic labs that conduct COVID-19 testing...
FreeLIMS, a cloud-based COVID-19 LIMS solution, enables laboratories to increase testing throughput and meet the unprecedented demand for COVID-19 testing and research. FreeLIMS enables COVID-19 testing laboratories to securely manage samples and test results, protect Personally Identifiable Information (PII) of patients, assure the accuracy of test results, and generate custom test reports with ease...
VectorBuilder – a global leader in vector design, optimization and GMP manufacturing – has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production. VectorBuilder’s manufacturing center in Guangzhou, China, will work with Univercells Technologies to develop and optimize platform processes for the production of custom viral vectors for cell and gene therapies, as well as vaccine applications....
Avacta Group plc, the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has entered into a non-exclusive distribution agreement with Calibre Scientific Inc. (“Calibre”), a global provider of life science products, for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test for professional use in the UK and European Economic Area (EEA)...
As the demand for rapid SARS-CoV-2 testing continues to grow, so does the need for accurate, reliable and fast results. Gilson’s new COVID-19 Testing Fluid News Brochure highlights their range of world-renown and trusted manual and automated lab solutions that can easily integrate into your qPCR and RT-Lamp testing workflows. When protection, speed of analysis, reliability and traceability are paramount, Gilson’s range of lab equipment and instruments delivers verifiable data and complete confidence in results...
The CEO of a British technology training firm and tech think tank has warned of a looming crisis facing UK laboratories – in particular those at the forefront of Covid-19 testing – due to a massive shortage of qualified and skilled lab technicians. Andy Lord, CEO of Manchester head-quartered Credersi, a tech talent training incubator and think tank producing the data scientists, lab technicians and software specialists of tomorrow, believes the skills shortage could severely impact Covid testing laboratories...
Porvair Sciences has further expanded its range of high-performance microplate products for SARS-CoV-2 nucleic acid purification. The new KF deep well plate and tip comb plate combo are specifically designed to enhance the performance and productivity of the market-leading Thermo Scientific™ KingFisher™ range of nucleic acid purification systems....
Anna Biosciences, a drug discovery company focused on novel therapies in immuno-oncology, virology, and neurodegenerative diseases, announces its entry in the fight against COVID-19 with the introduction of its immunotherapy platform, Syntem. The Anna Biosciences Syntem Platform deploys engineered proprietary molecules to create synthetic immunity...
AMSBIO invite the global research community to the 2021 annual meeting of the ISSCR, the leading professional organization of stem cell scientists, to discover how iPSCs and organoids can be used in COVID-19 drug discovery research. At this virtual meeting - Dr. Kazuo Takayama from the renowned Center for iPS Cell Research and application (CiRA) at Kyoto University will be giving a unique insight into his recent pioneering research...
Cherwell Laboratories, specialists in cleanroom microbiology solutions, announces that it has recently delivered its biggest ever single order for microbial air sampling equipment to support the large-scale manufacturing programme for COVID-19 vaccine supply. The new SAS air sampling equipment will be used for the environmental monitoring of the newly built UK-based Grade A manufacturing facilities of a key specialty vaccine company.
Developed by Curiosity Diagnostics, a wholly-owned subsidiary of Scope Fluidics S.A., the PCR|ONE SARS-CoV-2 panel is now CE-marked and can be introduced to the European market. The PCR|ONE SARS-CoV-2 panel is one of the fastest tests in the world, and is uniquely suited for near patient testing. The SARS-CoV-2 product expand the menu of test available on the PCR|ONE system, which already includes methicillin-resistant Staphylococcus aureus (MRSA/MSSA panel)....
As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launched a variety of lentiviral SARS-CoV-2 pseudovirus from a wide range of coronavirus species. Different vectors can be used to express different reporters such as EGFP or luciferase, allowing the monitoring of viral entry into host cells by a variety of means....
Illumina, Inc. has donated $1 million in sequencing capabilities to the Molecular Diagnostic Reference Laboratory at Kasturba Hospital, in the Municipal Corporate of Greater Mumbai, to help expand SARS-CoV-2 sequencing capabilities in the region and support the broader genomic surveillance effort across India. Kasturba Hospital was the first hospital in Mumbai to begin sequencing SARS-CoV-2 this year and will examine how variants of the virus are being spread across India....
Nanopharm Ltd., an Aptar Pharma company and leader in contract research and development of orally inhaled and nasally delivered drug products (OINDP) and Leyden Labs, a company targeting commonalities of viral families to protect humanity from known and future viruses, have announced that they have entered into an agreement to develop nasal sprays that may provide broad protection against respiratory viruses...
PharmEnable, an AI drug discovery company unlocking challenging biological targets, announces that it has entered into a drug discovery collaboration with LifeArc, an independent UK medical research charity, to apply their respective technologies and expertise to discover novel oral antiviral drugs with activity against coronaviruses....
At the start of the COVID-19 pandemic in March 2020, Dr Mason and his team set about turning their knowledge of functional genomics to sequencing and understanding the clinical impact of the SARS-CoV-2 virus. The lab developed multiple methods to detect infections, track strain evolution, and identify biomarkers of disease course to assist with clinical identification and treatment....
MolGen B.V., a single-source supplier of DNA/RNA extraction technology and services for the life sciences and biotechnology, announce its entrance into the U.S. market with the launch of MolGen USA, a joint venture with California-based, laboratory automation experts Todaro Robotics. MolGen USA will operate a complete commercial team and product showroom at the San Diego facility....
Severe COVID-19 and Rheumatoid Arthritis (RA) share some common pathogenic mechanisms, according to a new study. The observations from the study – published in JCI Insight and led by the University of Glasgow’s Research into Inflammatory Arthritis Centre (RACE) in collaboration with the Fondazione A.Gemelli IRCCS in Italy –could help development of new treatment strategies for severe COVID-19...
SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The partnership links specimen handling, nucleic acid extraction, assay set-up, amplification, and results reporting in a seamless integration of the companies technologies...
Owlstone Medical (or the “Company”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, has announced the publication of a peer-reviewed study in Nature Scientific Reports. The paper investigates the performance of filters embedded in face masks for supporting the detection of SARS-CoV-2 as an alternative to nasopharyngeal swabs (NPS)...
Designed and manufactured in the UK, Σ–MM™ solution rapidly kills all microorganisms, including bacteria, mycobacteria and viruses, rendering specimens safe for transport, whilst preserving and stabilizing RNA/DNA for accurate molecular analysis across diagnostic platforms. The Σ–MM™ device is a highly effective single step collection....
The race is on in the diagnostics industry to develop a device that instantly detects coronavirus for use in large public spaces and airports, according to one of the UK’s top medical technology recruiters. Ivor Campbell, chief executive of Snedden Campbell, said the biggest companies are chasing the ‘holy grail’ of a rapid-test, biosensing device – similar to that used to test blood sugar levels in diabetic patients – that will identify whether a patient has Covid within a matter of seconds...
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced the launch of the Reliance SARS-CoV-2/FluA/FluB™ RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements. The Reliance SARS-CoV-2/FluA/FluB™ RT-PCR Kit (IVD) is a single molecular test designed for clinical diagnostic labs that conduct COVID-19 testing...
FreeLIMS, a cloud-based COVID-19 LIMS solution, enables laboratories to increase testing throughput and meet the unprecedented demand for COVID-19 testing and research. FreeLIMS enables COVID-19 testing laboratories to securely manage samples and test results, protect Personally Identifiable Information (PII) of patients, assure the accuracy of test results, and generate custom test reports with ease... 
VectorBuilder – a global leader in vector design, optimization and GMP manufacturing – has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production. VectorBuilder’s manufacturing center in Guangzhou, China, will work with Univercells Technologies to develop and optimize platform processes for the production of custom viral vectors for cell and gene therapies, as well as vaccine applications....
Avacta Group plc, the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has entered into a non-exclusive distribution agreement with Calibre Scientific Inc. (“Calibre”), a global provider of life science products, for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test for professional use in the UK and European Economic Area (EEA)...
As the demand for rapid SARS-CoV-2 testing continues to grow, so does the need for accurate, reliable and fast results. Gilson’s new COVID-19 Testing Fluid News Brochure highlights their range of world-renown and trusted manual and automated lab solutions that can easily integrate into your qPCR and RT-Lamp testing workflows. When protection, speed of analysis, reliability and traceability are paramount, Gilson’s range of lab equipment and instruments delivers verifiable data and complete confidence in results...
The CEO of a British technology training firm and tech think tank has warned of a looming crisis facing UK laboratories – in particular those at the forefront of Covid-19 testing – due to a massive shortage of qualified and skilled lab technicians. Andy Lord, CEO of Manchester head-quartered Credersi, a tech talent training incubator and think tank producing the data scientists, lab technicians and software specialists of tomorrow, believes the skills shortage could severely impact Covid testing laboratories...
Porvair Sciences has further expanded its range of high-performance microplate products for SARS-CoV-2 nucleic acid purification. The new KF deep well plate and tip comb plate combo are specifically designed to enhance the performance and productivity of the market-leading Thermo Scientific™ KingFisher™ range of nucleic acid purification systems....
Anna Biosciences, a drug discovery company focused on novel therapies in immuno-oncology, virology, and neurodegenerative diseases, announces its entry in the fight against COVID-19 with the introduction of its immunotherapy platform, Syntem. The Anna Biosciences Syntem Platform deploys engineered proprietary molecules to create synthetic immunity...
AMSBIO invite the global research community to the 2021 annual meeting of the ISSCR, the leading professional organization of stem cell scientists, to discover how iPSCs and organoids can be used in COVID-19 drug discovery research. At this virtual meeting - Dr. Kazuo Takayama from the renowned Center for iPS Cell Research and application (CiRA) at Kyoto University will be giving a unique insight into his recent pioneering research...